XBIO
Xenetic Biosciences
$2.50
−$0.14 (−5.3%)Jul 27, 2026
Key metrics
The numbers that frame XBIO today
- Market cap
- $5.73M
- P/E (TTM)
- -2.6
- EV / FCF
- 0.9
- Gross margin
- 100%
- EV / Sales
- -0.5
- ROIC
- 647.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.90
- 52wk High
- $13.93
Growth
Revenue and earnings trend for XBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XBIO
Is Xenetic Biosciences a good buy?
No. Xenetic Biosciences has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of XBIO?
Xenetic Biosciences's market capitalization is $5.73M.
What is the P/E ratio for XBIO stock?
Xenetic Biosciences's current P/E ratio is -2.6.
What is the 52-week high for XBIO stock?
The 52-week high for Xenetic Biosciences is $13.93. The current close of $2.50 is 82.1% below that high.
What is the 52-week low for XBIO stock?
The 52-week low for Xenetic Biosciences is $1.90. The current close of $2.50 is 31.6% above that low.
Does XBIO stock pay dividends?
Xenetic Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XBIO?
Xenetic Biosciences's Debt / Equity ratio is 0.